Ana Tobar

3.9k total citations · 1 hit paper
51 papers, 2.1k citations indexed

About

Ana Tobar is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Nephrology. According to data from OpenAlex, Ana Tobar has authored 51 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 11 papers in Molecular Biology and 11 papers in Nephrology. Recurrent topics in Ana Tobar's work include Renal Diseases and Glomerulopathies (7 papers), Renal Transplantation Outcomes and Treatments (4 papers) and Systemic Lupus Erythematosus Research (4 papers). Ana Tobar is often cited by papers focused on Renal Diseases and Glomerulopathies (7 papers), Renal Transplantation Outcomes and Treatments (4 papers) and Systemic Lupus Erythematosus Research (4 papers). Ana Tobar collaborates with scholars based in Israel, United States and Czechia. Ana Tobar's co-authors include Uzi Gafter, Michal Herman‐Edelstein, Moshe Levi, Pnina Scherzer, Nathan Keller, Miri Blank, Mati Fridkin, Juri Kopolovic, Yehuda Shoenfeld and Ilan Krause and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Ana Tobar

50 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy

2013 471 citations Michal Herman‐Edelstein, Pnina Scherzer et al. Journal of Lipid Research profile →

Peers

Countries citing papers authored by Ana Tobar

Since Specialization

Citations

This map shows the geographic impact of Ana Tobar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Tobar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Tobar more than expected).

Fields of papers citing papers by Ana Tobar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Tobar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Tobar. The network helps show where Ana Tobar may publish in the future.

Co-authorship network of co-authors of Ana Tobar

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Tobar. A scholar is included among the top collaborators of Ana Tobar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Tobar. Ana Tobar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Oral N-acetylcysteine ameliorates liver fibrosis and enhances regenerative responses in Mdr2 knockout mice 2024 ·Scientific Reports ·Adi Har‐Zahav, Ana Tobar, (unknown), (unknown), Benjamin J. Wilkins, Pierre Russo, Ron Shamir, Rebecca G. Wells, Michael Gurevich, Orith Waisbourd‐Zinman	3
2	Complete digital pathology transition: A large multi-center experience 2023 ·Pathology - Research and Practice ·(unknown), (unknown), Ruthy Shaco‐Levy, Aviva Katzav, (unknown), (unknown), (unknown), (unknown), (unknown), Edmond Sabo, Ana Tobar, L. Sylvia	4
3	Beneficiary Effects of Colchicine on Inflammation and Fibrosis in a Mouse Model of Kidney Injury 2023 ·The Nephron journals/Nephron journals ·Daniel Landau, (unknown), (unknown), Ana Tobar, Yael Segev	2
4	PICT ‐1 regulates p53 splicing and sensitivity of medullary thyroid carcinoma cells to everolimus 2022 ·Journal of Neuroendocrinology ·(unknown), Ilan Shimon, Ana Tobar, Hadara Rubinfeld	1
5	The Role of Early Sequential Biopsies in Delayed Renal Graft Function of Transplanted Kidney Is Reduced in Modern Immunosuppression Era 2022 ·The Nephron journals/Nephron journals ·(unknown), (unknown), Ruth Rahamimov, Ana Tobar, M. Israeli, (unknown), Michael Gurevich, (unknown), (unknown), (unknown), (unknown), Eviatar Nesher	2
6	Portal plate bile duct diameter in biliary atresia is associated with long-term outcome 2022 ·Pediatric Surgery International ·(unknown), Ana Tobar, Yael Mozer‐Glassberg, (unknown), Raanan Shamir, (unknown), Michael Gurevich, Orith Waisbourd‐Zinman	0
7	Acute liver failure is regulated by MYC- and microbiome-dependent programs 2020 ·Nature Medicine ·Aleksandra A. Kolodziejczyk, Sara Federici, Niv Zmora, Gayatree Mohapatra, Mally Dori-Bachash, (unknown), Avner Leshem, Debby Reuveni, Ehud Zigmond, Ana Tobar, Tomer Meir Salame, Alon Harmelin, Amir Shlomai, Hagit Shapiro, Ido Amit, Eran Elinav	104
8	[TRMU MUTATIONS - REVERSIBLE INFANTILE LIVER FAILURE OR MULTISYSTEM DISORDER?] 2018 ·PubMed ·(unknown), Yael Mozer‐Glassberg, Ana Tobar, Shai Ashkenazi, Avraham Zeharia, Daphna Marom	5
9	Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy breakdown → 2013 ·Journal of Lipid Research ·Michal Herman‐Edelstein, Pnina Scherzer, Ana Tobar, Moshe Levi, Uzi Gafter	471
10	Different Patterns of Expression of the erbB Family of Receptor Tyrosine Kinases in Common Nevi, Dysplastic Nevi, and Primary Malignant Melanomas: An Immunohistochemical Study 2010 ·American Journal of Dermatopathology ·Meora Feinmesser, (unknown), Sara Morgenstern, Ana Tobar, Haim Gutman, Ella Kaganovsky, (unknown), Jaqueline Sulkes, Elimelech Okon	4
11	Determinants of Long-Term Graft Outcome in Transplant Glomerulopathy 2010 ·Transplantation ·Rohan John, Ana Konvalinka, Ana Tobar, S. Joseph Kim, Heather N. Reich, Andrew M. Herzenberg	38
12	Langerhans cell histiocytosis in a premature baby presenting with skin‐isolated disease: case report and literature review 2008 ·Acta Paediatrica ·Shraga Aviner, (unknown), Daniel A. London, Ana Tobar, Shmuel Zangen	8
13	Late-onset acute haemorrhagic necrotizing granulomatous adenovirus tubulointerstitial nephritis in a renal allograft 2007 ·Nephrology Dialysis Transplantation ·Khaled O. Alsaad, Ana Tobar, Eric C. Bélanger, M Ahmad, Daniel C. Cattran, Andrew M. Herzenberg	22
14	Inhibition of Interleukin-10 by the Immunomodulator AS101 Reduces Mesangial Cell Proliferation in Experimental Mesangioproliferative Glomerulonephritis 2004 ·Journal of Biological Chemistry ·Yona Kalechman, Uzi Gafter, Talia Weinstein, Avry Chagnac, (unknown), Ana Tobar, Michael Albeck, Benjamin Sredni	39
15	A case of langerhans’-cell histiocytosis with membranous nephropathy 2004 ·American Journal of Kidney Diseases ·(unknown), Eytan Cohen, (unknown), Ana Tobar, Moshe Garty	10
16	Administration of eptifibatide to acute coronary syndrome patients receiving enoxaparin or unfractionated heparin 2004 ·Journal of the American College of Cardiology ·Eli I. Lev, David Hasdai, Erez Scapa, Ana Tobar, Abid Assali, Judith Lahav, Alexander Battler, Juan J. Badimón, Ran Kornowski	13
17	Head or tail? 2003 ·Nephrology Dialysis Transplantation ·Tiberiu Hershcovici, (unknown), Vered Schechner, Ana Tobar, Yitzhak Beigel	1
18	Bacterial induction of autoantibodies to β2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome 2002 ·Journal of Clinical Investigation ·Miri Blank, Ilan Krause, Mati Fridkin, Nathan Keller, Juri Kopolovic, Iris Goldberg, Ana Tobar, Yehuda Shoenfeld	14
19	Bacterial induction of autoantibodies to β2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome 2002 ·Journal of Clinical Investigation ·Miri Blank, Ilan Krause, Mati Fridkin, Nathan Keller, Juri Kopolovic, Iris Goldberg, Ana Tobar, Yehuda Shoenfeld	236
20	Maxillomandibular brown tumor - a rare complication of chronic renal failure 2000 ·Pediatric Nephrology ·Irit Krause, Bella Eisenstein, Miriam Davidovits, Roxana Cleper, Ana Tobar, Shlomo Calderon	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact